A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer

Prostate Cancer: The Magnitude of the Problem in the United States.- Incidence, Survival and Mortality Trends in Prostate Cancer.- Localized Disease.- Incidental Cancer.- Diagnosis of Stage A Prostate Cancer in the People’s Republic of China.- Prevention of Prostatic Carcinogenesis — Is it Realistic?.- Tumor Volume and Natural History of Stage A1 and A2 Disease.- The Proto-Biology of Prostate Cancer.- The Classification and Prognosis of Untreated Stage A1 and A2 Prostate Cancer with a Comparison of Their Histologic Findings at Radical Prostatectomy.- Role of Histology in Selecting Treatment for Stage A1 and Stage A2 Disease.- Panel Discussion: Management of Stages A1 and A2 Disease.- Management of Clinically Manifest Stages B1 and B2 Disease.- External Beam Irradiation of Prostatic Cancer.- Long-Term Results After Combined Radioactive Gold Seed Implantation and External Beam Radiotherapy for Localized Prostatic Cancer.- Radical Prostatectomy for the Treatment of Localized Prostatic Cancer.- Panel Discussion: Management of Stages B1 and B2 Disease.- Invasive Disease.- Stages C, D0, and D1 Disease.- Adjuvant Radiotherapy Following Radical Prostatectomy: Results and Complications.- Treatment of Patients with Positive Margins.- The Long-Term Success of Local Radiation Therapy in Preventing Tumor Regrowth in the Treated Field.- Is Salvage Prostatectomy a Benefit?.- Accuracy of Grading and Staging Prostate Cancer.- Radical Prostatectomy and the Influence of Early Endocrine Therapy for Stage D1 Prostate Cancer: Long-Term Follow-Up Study.- Panel Discussion: Management of Stages C, D0 and D1 Disease.- Hormonal Treatment Approaches to D2 Disease.- The Case for Total Androgen Blockade in the Management of Metastatic Prostate Cancer.- Hormonal Therapy of Prostate Cancer:Limitations in the Total Androgen Ablation Concept.- Comparison of Total Androgen Blockade and Orchiectomy in Metastatic Cancer of Prostate.- A Randomized Prospective Evaluation of Leuprolide Versus Diethylstilbestrol in the Treatment of Stage D2 Metastatic Prostate Cancer: Results of a Multicenter Study.- Panel Discussion: Hormonal Treatment Approaches to D2 Disease.- Approaches to Discovering More Effective Treatments for Prostate Cancer.- Approaches to Discovering More Effective Treatments for Prostate Cancer — Early Diagnosis and Screening.- Clinical Trial Design for Cytotoxics in Prostate Cancer.- Panel Discussion: New Approaches.- Summations, Perspectives and Future Needs.- Committee Reports.- Excerpts of Minutes of Prostrate Cancer Working Group Committee Meeting on Diagnostic Nomenclature.- Grading Prostate Cancer — “As is our Pathology, So is Our Practice”.- Organ Systems Program Staging Classification for Prostate Cancer.- Response/Progression Criteria for Evaluating Prostate Cancer.- Guidelines for Reporting Studies of Treatment for Prostatic Cancer.- National Institutes of Health Consensus Development Conference Statement.- The Management of Clinically Localized Prostate Cancer.- Participants and Contributors.